Cardiopulmonary Exercise Testing (CPET) in Patients Treated with Schedule 2/1 and 4/2 for Metastic Renal Cell Carcinoma: A Randomized Multi-Site Trial
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Pfizer, Inc.
Start Date
December 20, 2016
End Date
June 1, 2021
Administered By
Duke Cancer Institute
Awarded By
Pfizer, Inc.
Start Date
December 20, 2016
End Date
June 1, 2021